Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Exercise lowers postprandial glucose but not fasting glucose in type 2 diabetes: a meta-analysis of studies using continuous glucose monitoring.

MacLeod SF, Terada T, Chahal BS, Boulé NG.

Diabetes Metab Res Rev. 2013 Nov;29(8):593-603. doi: 10.1002/dmrr.2461. Review.

PMID:
24038928
2.

The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.

Monnier L, Colette C, Dunseath GJ, Owens DR.

Diabetes Care. 2007 Feb;30(2):263-9.

PMID:
17259492
4.

Targeting specific interstitial glycemic parameters with high-intensity interval exercise and fasted-state exercise in type 2 diabetes.

Terada T, Wilson BJ, Myette-Cόté E, Kuzik N, Bell GJ, McCargar LJ, Boulé NG.

Metabolism. 2016 May;65(5):599-608. doi: 10.1016/j.metabol.2016.01.003. Epub 2016 Jan 11.

PMID:
27085769
5.

Continuous glucose monitoring systems for type 1 diabetes mellitus.

Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2. Review.

PMID:
22258980
6.
7.

The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes.

Johnson SL, McEwen LN, Newton CA, Martin CL, Raskin P, Halter JB, Herman WH.

J Diabetes Complications. 2011 Jul-Aug;25(4):211-5. doi: 10.1016/j.jdiacomp.2010.09.005. Epub 2010 Nov 9.

PMID:
21062674
8.

The acute effects of interval- Vs continuous-walking exercise on glycemic control in subjects with type 2 diabetes: a crossover, controlled study.

Karstoft K, Christensen CS, Pedersen BK, Solomon TP.

J Clin Endocrinol Metab. 2014 Sep;99(9):3334-42. doi: 10.1210/jc.2014-1837. Epub 2014 Jun 6.

PMID:
24905068
9.

Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes.

Hanefeld M, Koehler C, Hoffmann C, Wilhelm K, Kamke W, Gerstein H.

Diabet Med. 2010 Feb;27(2):175-80. doi: 10.1111/j.1464-5491.2009.02915.x.

PMID:
20546261
10.

Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

Rom J Intern Med. 2003;41(2):153-62.

PMID:
15526500
11.
13.
14.

Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.

Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, Gerich JE, Göke B.

Diabetes Res Clin Pract. 2007 Aug;77(2):280-5. Epub 2007 Jan 22.

PMID:
17240473
15.

The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review.

Chetty VT, Almulla A, Odueyungbo A, Thabane L.

Diabetes Res Clin Pract. 2008 Jul;81(1):79-87. doi: 10.1016/j.diabres.2008.02.014. Epub 2008 Apr 15. Review.

PMID:
18417243
16.

Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.

Bonora E.

Int J Clin Pract Suppl. 2002 Jul;(129):5-11. Review.

PMID:
12166607
17.

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

Bastyr EJ 3rd, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE.

Diabetes Care. 2000 Sep;23(9):1236-41.

18.

Monitoring exercise-induced changes in glycemic control in type 2 diabetes.

MacDonald AL, Philp A, Harrison M, Bone AJ, Watt PW.

Med Sci Sports Exerc. 2006 Feb;38(2):201-7.

PMID:
16531885
19.

Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements.

Dailey G.

Mayo Clin Proc. 2007 Feb;82(2):229-35; quiz 236. Review.

PMID:
17290732
20.

Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.

Chappuis B, Braun M, Stettler C, Allemann S, Diem P, Lumb PJ, Wierzbicki AS, James R, Christ ER.

Diabetes Metab Res Rev. 2007 Jul;23(5):392-9.

PMID:
17211855

Supplemental Content

Support Center